Testing Ashkenazis aged 30-65 for breast cancer gene is cost effective
Testing all Ashkenazi Jewish women for a variant of the BRCA gene that greatly increases the risk of breast and ovarian cancer – instead of only women at high risk due to family history – has been found to be cost-effective. The analysis by researchers at Jerusalem’s Shaare Zedek Medical Center, the Hebrew University’s Faculty […]
Continue Reading